All the news

People with hepatitis C virus (HCV) genotype 1b respond better to boceprevir and are less likely to develop drug resistance than those with genotype 1a, according to study findings reported ...

Specially trained primary care providers can offer effective and safe treatment for hepatitis C infection, US investigators report in the New England Journal of Medicine. Rates of sustained virological response were the ...

Coffee drinking is associated with improved responses to hepatitis C therapy, US investigators report in Gastroenterology. After adjustment for other factors, drinking three or more cups of coffee per day increased the chances of ...

HIV-positive individuals with acute hepatitis C may be able to clear the infection with just 24 weeks of therapy, Dutch research published in the online edition of AIDS suggests. The retrospective study involved 50 ...

The presence of a genetic variation in the IL28B gene is associated with better response rates to hepatitis C therapy in patients who are co-infected with HIV and hepatitis C, Spanish investigators ...

Antiretroviral therapy helps preserve the CD4 cell counts of HIV-positive patients undergoing treatment for hepatitis C, Austrian investigators report in the June 15th edition of the Journal of Infectious Diseases. Treatment with ...

Even before new hepatitis C drugs come to market later this year, the vast array of hepatitis C antivirals currently in clinical trials is opening up new horizons for treatment of hepatitis ...

Just over one-quarter of gay men with HIV successfully treated for acute hepatitis C infection became reinfected with hepatitis C within two years, almost all with a different genotype, Amsterdam doctors reported last ...

The experimental hepatitis C virus (HCV) protease inhibitor telaprevir, used with pegylated interferon plus ribavirin, produced good virological response in the first study of HIV/HCV co-infected individuals, according to interim data presented on Wednesday ...